PMID- 8795126 OWN - NLM STAT- MEDLINE DCOM- 19961122 LR - 20191101 IS - 1059-1311 (Print) IS - 1059-1311 (Linking) VI - 5 IP - 2 DP - 1996 Jun TI - Mechanisms of T-type calcium channel blockade by zonisamide. PG - 115-9 AB - We investigated the effects of zonisamide, a new antiepileptic drug, on voltage-dependent T-type calcium current (ICa) in cultured neuroblastoma cells of human origin (NB-I). Zonisamide reduced T-type ICa in a concentration-dependent manner without evoking any change in its inactivation kinetics or voltage dependence of action. The mean percent reduction was 38.3 +/- 5.8% at 50 microM. Further, zonisamide shifted the inactivation curve approximately 20 mV negative compared to the control. These resting blocking actions suggest that zonisamide shifts the channel population toward the inactivation state, allowing fewer channels to open during membrane depolarization. The blockade of T-type calcium channels by zonisamide could suppress an important component of inward current that underlies epileptiform cellular bursting, thereby inhibiting the spread of seizure activity. FAU - Kito, M AU - Kito M AD - Department of Pediatrics, Minami Seikyo Hospital, Nagoya, Japan. FAU - Maehara, M AU - Maehara M FAU - Watanabe, K AU - Watanabe K LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Seizure JT - Seizure JID - 9306979 RN - 0 (Anticonvulsants) RN - 0 (Calcium Channel Blockers) RN - 0 (Isoxazoles) RN - 459384H98V (Zonisamide) SB - IM MH - Anticonvulsants/*pharmacology MH - Calcium Channel Blockers/*metabolism MH - Cell Culture Techniques MH - Epilepsy/drug therapy MH - Humans MH - Isoxazoles/*pharmacology MH - Neuroblastoma/*drug therapy MH - Zonisamide EDAT- 1996/06/01 00:00 MHDA- 1996/06/01 00:01 CRDT- 1996/06/01 00:00 PHST- 1996/06/01 00:00 [pubmed] PHST- 1996/06/01 00:01 [medline] PHST- 1996/06/01 00:00 [entrez] AID - S1059-1311(96)80104-X [pii] AID - 10.1016/s1059-1311(96)80104-x [doi] PST - ppublish SO - Seizure. 1996 Jun;5(2):115-9. doi: 10.1016/s1059-1311(96)80104-x.